109 related articles for article (PubMed ID: 11276360)
1. Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis.
Hu X; Zuckerman KS
J Hematother Stem Cell Res; 2001 Feb; 10(1):67-74. PubMed ID: 11276360
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
Hu X; Zuckerman KS
Leuk Lymphoma; 2000 Jul; 38(3-4):235-46. PubMed ID: 10830731
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
Hu XT
Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
[TBL] [Abstract][Full Text] [Related]
5. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
7. The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes.
Herzinger T; Wolf DA; Eick D; Kind P
Oncogene; 1995 Jun; 10(11):2079-84. PubMed ID: 7784052
[TBL] [Abstract][Full Text] [Related]
8. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
10. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
12. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
Arvanitakis L; Yaseen N; Sharma S
J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
[TBL] [Abstract][Full Text] [Related]
13. Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue.
Mori A; Higashi H; Hoshikawa Y; Imamura M; Asaka M; Hatakeyama M
Oncogene; 1999 Nov; 18(46):6209-21. PubMed ID: 10597219
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 modulates p107 function in myeloid cells: correlation with cell cycle progression.
Bang OS; Ruscetti FW; Lee MH; Kim SJ; Birchenall-Roberts MC
J Biol Chem; 1996 Mar; 271(13):7811-9. PubMed ID: 8631825
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at serine 795.
Hu X; Moscinski LC; Zuckerman KS
Exp Hematol; 1999 Apr; 27(4):605-14. PubMed ID: 10210318
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.
Yan Z; Hsu S; Winawer S; Friedman E
Oncogene; 1992 Apr; 7(4):801-5. PubMed ID: 1565477
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
19. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
[TBL] [Abstract][Full Text] [Related]
20. Regulation and activity of the retinoblastoma protein family in growth factor-deprived and TGF(beta)-treated keratinocytes.
Belbrahem A; Godden-Kent D; Mittnacht S
Exp Cell Res; 1996 Jun; 225(2):286-93. PubMed ID: 8660916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
